Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis

Joint Bone Spine. 2014 Mar;81(2):190-2. doi: 10.1016/j.jbspin.2013.07.011. Epub 2013 Aug 9.

Authors

Francesco Caso¹, Ugo Fiocco¹, Luisa Costa¹, Paolo Sfriso¹, Leonardo Punzi¹, Andrea Doria²

Affiliations

¹ Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
² Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy. Electronic address: [email protected].

PMID: 23932926
DOI: 10.1016/j.jbspin.2013.07.011

No abstract available

Keywords: Anti-CD20 monoclonal antibody (rituximab); IgG4-RD; Scleritis.

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Humans
Hypergammaglobulinemia / complications
Hypergammaglobulinemia / drug therapy*
Hypergammaglobulinemia / immunology
Immunoglobulin G / immunology*
Immunologic Factors / therapeutic use*
Male
Rituximab
Scleritis / drug therapy*
Scleritis / immunology

Substances

Antibodies, Monoclonal, Murine-Derived
Immunoglobulin G
Immunologic Factors
Rituximab